View More Recent Stories

May 15, 2025 10:17AM HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions
May 13, 2025 08:04AM HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute
May 5, 2025 08:03AM NRx Pharmaceuticals (NRXP) Files Patent Application for NRX-100
Apr 3, 2025 08:03AM NRx Pharmaceuticals (NRXP) and HOPE Sign Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE
Apr 2, 2025 06:07AM BTIG Starts NRx Pharmaceuticals, Inc. (NRXP) at Buy
Mar 31, 2025 08:02AM NRx Pharmaceuticals (NRXP) and HOPE Announce Definitive Purchase Agreement with Dura Medical
Mar 24, 2025 08:03AM NRx Pharmaceuticals (NRXP) and HOPE Therapeutics Sign LoI with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics
Mar 20, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
Jan 28, 2025 08:05AM NRx Pharmaceuticals (NRXP) and HOPE Therapeutics Execute Agreement for $27M Funding Transaction for HOPE Clinic Acquisition
Jan 28, 2025 08:04AM NRx Pharmaceuticals (NRXP) Advances Relationship with Anson Funds with $8.9M Financing
Jan 21, 2025 08:03AM NRx Pharmaceuticals (NRXP) Regains Nasdaq Compliance
Jan 15, 2025 08:03AM NRx Pharmaceuticals (NRXP) Appoints Michael Taylor to its Board, Anita Nunes as Board Observer
Dec 30, 2024 08:04AM NRx Pharmaceuticals (NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100
Nov 25, 2024 06:54AM H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
Nov 18, 2024 04:05PM NRx Pharmaceuticals (NRXP) Appoints Michael Abrams as Chief Financial Officer
Nov 13, 2024 08:03AM NRx Pharmaceuticals (NRXP) Reschedules Q3 Call
Oct 30, 2024 07:47AM NRx Pharmaceuticals' (NRXP) HOPE Therapeutics Announce Signing of a LoI to Acquire its First Florida Interventional Psychiatry Clinics
Oct 21, 2024 07:06AM EF Hutton Starts NRx Pharmaceuticals, Inc. (NRXP) at Buy
Oct 3, 2024 06:56AM NRx Pharmaceuticals (NRXP) and HOPE Therapeutics to Acquire a Premier West Coast Interventional Psychiatric Clinic
Sep 30, 2024 07:07AM NRx Pharmaceuticals (NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100
Aug 26, 2024 07:56AM HOPE Therapeutics and NRx Pharmaceuticals (NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics
Aug 20, 2024 04:45PM NRx Pharmaceuticals (NRXP) Announces CEO Resignation
Aug 13, 2024 07:31AM NRx Pharmaceuticals (NRXP) Announces Up to $16M Secured Debt Financing from Anson Funds
Jul 29, 2024 08:36AM HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100
Jul 29, 2024 08:35AM HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NRXP) Announce Arbitration Order Enabling HOPE Therapeutics Spinoff
Jul 1, 2024 08:07AM NRx Pharmaceuticals (NRXP) Issues Shareholder Letter
Jun 28, 2024 08:07AM NRx Pharmaceuticals (NRXP) to Proceed with Two New Drug Applications in 2024, NRX-101 Returned to the Company for Filing
Jun 18, 2024 08:32AM NRx Pharmaceuticals (NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors
Jun 10, 2024 08:31AM NRx Pharmaceuticals (NRXP) Issues Shareholder Update Letter
View More Recent Stories